登录 | 注册
产品搜索
购物车
产品名称 数量 现价 小计

合计:¥ .00

产品详情
Order NO.: RC034-2ug 品牌 : BBI
Recombinant Human Vascular Endothelial Growth Factor165
英文名 Recombinant Human Vascular Endothelial Growth Factor165
别名 C610034-0002
储存 This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
相关类别 重组蛋白
分子量 Recombinant human VEGF165 is a 38.6 kDa disulfide-linked homodimeric protein consisting of two 165 amino acid polypeptide chains with Met at N-terminus.
产品编号 新编号 包装规格 库存 目录价(元) 网购价(元) 订购数量
RC034-2ug C610034-0002 2 μg 525.0 420.0
      大包装请询
Usage
This material is offered by Sangon Biotech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE.
General Description
Vascular Endothelial Growth Factor is a sub-family of growth factors produced by cells, which stimulates vasculogenesis and angiogenesis. VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels. Humans express alternately spliced isoforms of 121, 145, 165, 183, 189, and 206 amino acids (a.a.) in length. VEGF production can be induced in cells that are not receiving enough oxygen. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. Recombinant human VEGF165 contains 165 amino acids residues and it is a disulfide-linked homodimer. In addition, it shares 88 % a.a. with corresponding regions of mouse and rat, 96 % with porcine, 95 % with canine, and 93 % with feline, equine and bovine VEGF, respectively.
Properties
AA Sequence MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEIEYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD RARQENPCGP CSERRKHLFV QDPQTCKCSC KNTDSRCKAR QLELNERTCR CDKPRR
Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Endotoxin Less than 1 EU/μg of rHuVEGF165 as determined by LAL method.
Formulation Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder.
Biological Activity Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/ml.
Source Escherichia coli.
Purity > 95 % by SDS-PAGE and HPLC analyses.
生工生物工程(上海)有限公司 版权所有 沪ICP备07025263
上海市松江区香闵路698号
021-37772169  800-820-1016   400-821-0268      021-37772170       sales@sangon.com
ERP企业管理软件